CCC(C)N(C(=O)COC(=O)c1cn(CC)c2nc(C)ccc2c1=O)C1CCS(=O)(=O)C1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?